LGVN · Longeveron Inc.

NasdaqHealthcareBiotechnology

Longeveron Inc Is A Clinical Stage Biotechnology Company Developing Regenerative Medicines To Address Unmet Medical Needs. Its Investigational Product Candidate Is Laromestrocel. Laromestrocel Is A Proprietary, Scalable, Allogeneic Cellular Therapy That Has Multiple Potential Modes Of Action That Include Pro-Vascular, Pro-Regenerative, And Anti-Inflammatory Mechanisms That Collectively Appear To Promote Tissue Repair And Healing. It Is In Clinical Development Of A Single Investigational Product Candidate, Laromestrocel, For Four Potential Indications: Hlhs, Alzheimer'S Disease (Ad), Pediatric Dilated Cardiomyopathy (Pediatric Dcm), And Aging-Related Frailty. It Operates In A Single Operating Segment Focused On Developing Regenerative Medicines To Address Unmet Medical Needs.

HealthcareNasdaqUSVery Low Float

FLOAT

2.6M

FREE FLOAT %

86%

SHARES O/S

3.0M

MARKET CAP

$5.1M

EXCHANGE

Nasdaq

COUNTRY

LGVN Catalyst History

No catalysts recorded for LGVN yet

Day Trader Sniper hasn't classified a publishable catalyst for LGVN yet. New events appear here as they're scored.

Be early on the next LGVN spark.

Day Trader Sniper alerts you the instant a setup like this triggers.

How it works Download Free →

Every Second Counts.Don't Trade Without a Real-Time sparker alert.

LGVN · Longeveron Inc.

LGVN Catalyst History

Every Second Counts.
Don't Trade Without a Real-Time sparker alert.